Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
102.90    -0.10 (-0.10%)
Bid:
102.40
Ask:
102.70
Spread: 0.30 (0.293%)
Market Cap: £381.93m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

AI and Technology Teach In

10 Oct 2023 07:00

RNS Number : 4865P
RWS Holdings PLC
10 October 2023

10 October 2023

RWS Holdings plc ("RWS", "the Group", "the Company")

AI and Technology Teach In

RWS Holdings plc ("RWS" or "the Group"), a unique world-leading provider of technology-enabled language, content and intellectual property services, is today hosting an Artificial Intelligence ("AI") and technology-focused teach in, starting at 2.00pm BST.

During today's event, the Group will demonstrate how it has been pursuing the strategy set out at its Capital Markets Day in 2022, with a specific focus on opportunities to drive both growth and efficiency through its unique range of AI and technology products, its AI-oriented services and its operating platform.

The event will set out the key differentiators that position RWS to be a beneficiary of AI and technology through a series of presentations from leaders across the Group that:

· explain how AI and technology are critical to RWS and its industry?, with evolving technologies having enabled the growth of the industry over decades;

· showcase the depth of the Group's capabilities, well-established product and service offering and longstanding expertise in AI and technology;

· illustrate how RWS sees AI contributing to growth and efficiency;

· demonstrate the symbiosis between AI and human intelligence in RWS's unique blend of service and technology, which brings synergies through the ability to innovate and train AI models in-house and unrivalled insight into the needs of the users of the technologies;

· outline some of its future AI and technology developments; and

· show that, as a long-standing partner, clients are trusting RWS to help them successfully navigate the responsible and ethical application of enterprise-grade AI solutions.

Live demonstrations of the Group's Language Weaver, Trados, Tridion and TrainAI offerings will also take place during the break and after the conclusion of the presentations.

No new material information will be disclosed about trading. An update on trading for the year ended 30 September 2023 is scheduled to be issued on 25 October 2023.

Ian El-Mokadem, Chief Executive Officer of RWS, commented:

"As set out in our Capital Markets Day in March 2022, RWS has recognised the importance of AI and technology for our Group and across our industry for some time. We continue to build on our track record of harnessing new technologies to better serve our clients across increasing volumes of more complex content.

"As we capitalise on our scale, long-standing expertise and well-established products to drive growth and efficiencies across our business, we are well positioned to be a beneficiary of AI."

Registration for, and recording of, the teach in:

To register your interest in the teach in webcast, please email rws@mhpc.com. A recording will be available on the investor relations page of the website (www.rws.com) following the event.

For further information, please contact:

RWS Holdings plc

Ian El-Mokadem, Chief Executive Officer

Candida Davies, Chief Financial Officer

01753 480200

MHP (Financial PR Advisor)

Katie Hunt / Eleni Menikou / Catherine Chapman

rws@mhpgroup.com

020 3128 8100

07884 494 112

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank / Will Baunton

020 7260 1000

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Alix Mecklenburg-Solodkoff

020 3207 7800

About RWS

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L).

For further information, please visit: www.rws.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCNKCBDBBDBQKK
Date   Source Headline
1st Oct 20257:00 amRNSTotal Voting Rights
1st Sep 20253:09 pmRNSTotal Voting Rights
28th Aug 20257:00 amRNSHolding(s) in Company
18th Aug 20257:00 amRNSHolding(s) in Company
8th Aug 202511:11 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
28th Jul 20259:25 amRNSHolding(s) in Company
23rd Jul 20254:29 pmRNSHolding(s) in Company
18th Jul 20251:19 pmRNSHolding(s) in Company - amendment
16th Jul 20254:01 pmRNSHolding(s) in Company
2nd Jul 20259:00 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSChange of Nominated Adviser
26th Jun 202511:00 amRNS-RAcquisition of IP of Papercup
23rd Jun 202510:46 amRNSHolding(s) in Company
18th Jun 202512:30 pmRNSHolding(s) in Company
18th Jun 202510:12 amRNSHolding(s) in Company
17th Jun 202511:29 amRNSFurther re Half Year Report
17th Jun 20257:00 amRNSHalf-year Report
11th Jun 20257:00 amRNSHolding(s) in Company
10th Jun 20257:00 amRNSHolding(s) in Company
6th Jun 20257:00 amRNSHolding(s) in Company
2nd Jun 20257:00 amRNSTotal Voting Rights
12th May 20259:15 amRNS-RAppointment of Chief Product & Technology Officer
8th May 202511:51 amRNSDirector/PDMR Shareholding
6th May 202510:10 amRNSHolding(s) in Company
2nd May 20259:15 amRNSHolding(s) in Company
1st May 20252:15 pmRNSDirector/PDMR Shareholding
1st May 20257:00 amRNSTotal Voting Rights
30th Apr 20257:00 amRNSHolding(s) in Company
29th Apr 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSHolding(s) in Company
25th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Statement
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSChange of Registered Office
3rd Mar 20258:55 amRNSTotal Voting Rights
14th Feb 20253:51 pmRNSHolding(s) in Company
13th Feb 202512:33 pmRNSDirector/PDMR Shareholding
11th Feb 202512:14 pmRNSResult of AGM
11th Feb 20257:00 amRNSAGM Statement
10th Feb 20254:57 pmRNSHolding(s) in Company
3rd Feb 20255:00 pmRNSDirector/PDMR Shareholding
3rd Feb 20254:58 pmRNSDirector/PDMR Shareholding
3rd Feb 20257:00 amRNSTotal Voting Rights
28th Jan 20252:06 pmRNSDirector/PDMR Shareholding
28th Jan 20252:04 pmRNSDirector/PDMR Shareholding
28th Jan 20252:01 pmRNSDirector/PDMR Shareholding
23rd Jan 20253:58 pmRNSOption Exercise, Admission and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.